Vaccines

The Biden administration has maintained that the third shot is not necessary.

The association says that the vaccines are safe and effective at reducing the risk of infection and transmission.

A new study claims the single-dose vaccine is less effective against emerging variants than previously believed.

The CDC is examining booster shots against COVID-19 for immunocompromised patients.

A statement calls for vaccination requirements for employees of hospitals, nursing homes, and other healthcare facilities.

A large portion of young adults are still saying they likely won’t get the shots.

The FDA and CDC say the booster isn’t currently necessary.

Without the COVID-19 vaccine nearly twice as many people in the U.S. would have died of the disease this year.

Results from an ongoing research project tracking Americans’ experiences with, and attitudes towards, COVID-19 vaccinations.

Researchers say Ohio’s “Vax-a-Million” lottery wasn’t associated with an increased number of vaccinations.

In a U.K trial, the drug proved 96 percent efficacy against the original strain of COVID-19.

The policy says physicians have an ethical obligation to advocate for the health and wellbeing of patients globally.

In a letter to physicians and insurers, the HHS head reminds that patients can’t be charged for the vaccine.

Moderna will seek to expand their EUA cover administering the vaccine to children under 18 years old.

The move is expected to spur more Americans to get the jabs.

The Pfizer vaccine can now be administered to adolescents between the age of 12 and 15.

The drug maker has started the biologics license application process.

The new codes will be for use if the Novavax COVID-19 vaccine candidate is approved or receives an EUA.

The White House says the administration will ramp up vaccination efforts to hit at least 160 million fully vaccinated adults by July 4.

Data from the Coronavirus Resource Center at Johns Hopkins University and the Centers for Disease Control.

A federal advisory committee says the COVID-19 vaccine is safe, but many Americans says they won’t take it.

The NIH’s investments in vaccine technology before the pandemic paid dividends in the development of COVID-19 vaccines.

The CEO of the drug company says that a booster followed by annual vaccinations will likely be needed to defeat the pandemic.

ACIP delayed a vote on lifting a federal pause on the single-dose COVID-19 vaccine.

U.S. regulators is taking a pause on administering the vaccine while experts study a small number of blood clots.